Breakthroughs and challenges of CAR-T cell therapy in treating hematologic malignancies of the central nervous system
{{output}}
Chimeric antigen receptor T (CAR-T) cell therapy has transformed hematologic cancer treatment; however, its application in patients with central nervous system (CNS) involvement remains challenging because of exclusion from key trials. Recent data show that CA... ...
